Table 2.
Pathway | Database | p-Value | #Genes | #miRNAs |
---|---|---|---|---|
TGF-beta signaling pathway | microT-CDS/Tarbase | 0.006/0.036 | 21/6 | 8/1 |
Proteoglycans in cancer | microT-CDS | <0.001 | 41 | 9 |
Long-term depression | TargetScan | 0.002 | 13 | 5 |
Glutamatergic synapse | microT-CDS | 0.006 | 26 | 8 |
Thyroid hormone signaling pathway | microT-CDS | 0.006 | 26 | 9 |
Amphetamine addiction | microT-CDS | 0.024 | 16 | 7 |
Morphine addiction | microT-CDS | 0.025 | 22 | 8 |
Endocrine and other factor-regulated calcium reabsorption | microT-CDS | 0.027 | 13 | 6 |
Calcium signaling pathway | microT-CDS | 0.027 | 36 | 8 |
Hippo signaling pathway | microT-CDS | 0.027 | 28 | 8 |
Signaling pathways regulating pluripotency of stem cells | microT-CDS | 0.027 | 27 | 9 |
Dilated cardiomyopathy | microT-CDS | 0.027 | 22 | 9 |
MAPK signaling pathway | microT-CDS | 0.028 | 49 | 9 |
Circadian entrainment | microT-CDS | 0.028 | 24 | 9 |
Colorectal cancer | microT-CDS | 0.038 | 13 | 5 |
ErbB signaling pathway | microT-CDS | 0.038 | 17 | 7 |
ECM-receptor interaction | microT-CDS | 0.038 | 16 | 7 |
Axon guidance | microT-CDS | 0.038 | 25 | 8 |
Cytokine-cytokine receptor interaction | microT-CDS | 0.038 | 37 | 9 |
Endocytosis | microT-CDS | 0.038 | 37 | 10 |
Focal adhesion | microT-CDS | 0.049 | 40 | 10 |